Biolidics Past Earnings Performance
Past criteria checks 0/6
Biolidics has been growing earnings at an average annual rate of 0.4%, while the Medical Equipment industry saw earnings growing at 8.4% annually. Revenues have been declining at an average rate of 28.5% per year.
Key information
0.4%
Earnings growth rate
13.7%
EPS growth rate
| Medical Equipment Industry Growth | 16.4% |
| Revenue growth rate | -28.5% |
| Return on equity | n/a |
| Net Margin | -215.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Biolidics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1 | -3 | 1 | 0 |
| 30 Jun 24 | 1 | -3 | 2 | 0 |
| 31 Mar 24 | 0 | -3 | 2 | 0 |
| 31 Dec 23 | 1 | -2 | 2 | 0 |
| 30 Sep 23 | 1 | -8 | 2 | 0 |
| 30 Jun 23 | 2 | -8 | 2 | 0 |
| 31 Mar 23 | 3 | -9 | 3 | 0 |
| 31 Dec 22 | 3 | -9 | 3 | 0 |
| 30 Sep 22 | 2 | -5 | 2 | 1 |
| 30 Jun 22 | 2 | -5 | 2 | 1 |
| 31 Mar 22 | 2 | -6 | 2 | 1 |
| 31 Dec 21 | 2 | -6 | 2 | 1 |
| 30 Sep 21 | 3 | -7 | 2 | 1 |
| 30 Jun 21 | 3 | -8 | 3 | 1 |
| 31 Mar 21 | 6 | -6 | 3 | 1 |
| 31 Dec 20 | 9 | -5 | 3 | 1 |
| 30 Sep 20 | 9 | -4 | 2 | 1 |
| 30 Jun 20 | 8 | -3 | 1 | 1 |
| 31 Mar 20 | 5 | -4 | 1 | 1 |
| 31 Dec 19 | 2 | -5 | 2 | 1 |
| 30 Sep 19 | 2 | -5 | 2 | 1 |
| 30 Jun 19 | 2 | -5 | 1 | 1 |
| 31 Mar 19 | 2 | -6 | 2 | 1 |
| 31 Dec 18 | 1 | -6 | 2 | 1 |
| 30 Sep 18 | 1 | -6 | 2 | 1 |
| 30 Jun 18 | 2 | -6 | 2 | 1 |
| 31 Mar 18 | 2 | -7 | 2 | 1 |
| 31 Dec 17 | 2 | -7 | 2 | 1 |
| 31 Dec 16 | 2 | -7 | 1 | 2 |
| 31 Dec 15 | 1 | -8 | 1 | 2 |
Quality Earnings: 8YY is currently unprofitable.
Growing Profit Margin: 8YY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 8YY is unprofitable, but has reduced losses over the past 5 years at a rate of 0.4% per year.
Accelerating Growth: Unable to compare 8YY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 8YY is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-2.6%).
Return on Equity
High ROE: 8YY's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.